Ardee, Ireland-based Warner Chilcott, which recently shifted base from Rockaway, New Jersey, is expected to run the acquired business as a wholly-owned unit. Both the companies were unavailable to comment. The report stated that others in the fray to buy the unit were private equity firm Cerberus Capital Management and rival drug-maker Forest Laboratories.
Monday, August 24, 2009
Warner Chilcott win
Sunday, according to The Wall Street Journal, specialty drug maker Warner Chilcott is acquiring the prescription-drug business of consumer goods giant Procter & Gamble. The report stated that the pharmaceutical unit could fetch about $3 billion, and that the official announcement on a deal could be made as early as Monday. The company's Ohio-based pharmaceutical unit was on the block for sale since December 2008.
Ardee, Ireland-based Warner Chilcott, which recently shifted base from Rockaway, New Jersey, is expected to run the acquired business as a wholly-owned unit. Both the companies were unavailable to comment. The report stated that others in the fray to buy the unit were private equity firm Cerberus Capital Management and rival drug-maker Forest Laboratories.
Ardee, Ireland-based Warner Chilcott, which recently shifted base from Rockaway, New Jersey, is expected to run the acquired business as a wholly-owned unit. Both the companies were unavailable to comment. The report stated that others in the fray to buy the unit were private equity firm Cerberus Capital Management and rival drug-maker Forest Laboratories.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment